Advances in Cancer Biomarkers From biochemistry to clinic for a critical revision /

At present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes.  Intriguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clam...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Scatena, Roberto. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Dordrecht : Springer Netherlands : Imprint: Springer, 2015.
Edition:1st ed. 2015.
Series:Advances in Experimental Medicine and Biology, 867
Subjects:
Online Access:https://doi.org/10.1007/978-94-017-7215-0
LEADER 03957nam a22005175i 4500
001 978-94-017-7215-0
003 DE-He213
005 20210618212344.0
007 cr nn 008mamaa
008 151103s2015 ne | s |||| 0|eng d
020 |a 9789401772150  |9 978-94-017-7215-0 
024 7 |a 10.1007/978-94-017-7215-0  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a Advances in Cancer Biomarkers  |h [electronic resource] :  |b From biochemistry to clinic for a critical revision /  |c edited by Roberto Scatena. 
250 |a 1st ed. 2015. 
264 1 |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2015. 
300 |a IX, 372 p. 27 illus., 21 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 867 
505 0 |a Prelims -- I Generality.- II Tumor markers-a critical revision -- Enzymes.- Hormones -- Oncofetal proteins.- Cytokeratins -- Carbohydrate markers -- Blood group antigens.- Genetic markers -- Various protein markers -- III Perspectives.- The role of Circulating tumor Cells as tumor markers -- Index. 
520 |a At present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes.  Intriguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clamorous failures. Also from a clinical point of view, there are contradictory results on routine clinical use of the present cancer biomarkers. Some patients may be simply  monitored in their course by a periodic blood sample, but sometimes this monitoring shows dramatic limits. A lot of patients show serious and extensive relapses without significant change in serum concentrations of biomarkers tested. Often the physician who should utilize these biomarker does not entirely  know their limits and the total potential applications as well and sometimes this knowledge is influenced by economical and marketing strategies. This limited and “polluted” knowledge may have dramatic consequences for patient.  The aim of this book is to diffuse all aspects of cancer biomarkers, from their biochemical peculiarities to all clinical implications by passing through their physiology and pathophysiology. This critical approach towards old and new cancer biomarkers should foster a deepened and useful understanding of the diagnostic and prognostic index of these fundamental parameters of laboratory medicine and in the same time facilitating the research of new and more sensitive-specific signals of the cancer cell proliferation. 
650 0 |a Cancer research. 
650 0 |a Oncology  . 
650 0 |a Pharmacology. 
650 1 4 |a Cancer Research.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B11001 
650 2 4 |a Oncology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33160 
650 2 4 |a Pharmacology/Toxicology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B21007 
700 1 |a Scatena, Roberto.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9789401772143 
776 0 8 |i Printed edition:  |z 9789401772167 
776 0 8 |i Printed edition:  |z 9789402404203 
830 0 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 867 
856 4 0 |u https://doi.org/10.1007/978-94-017-7215-0 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)